Skip to content
Emzor Pharmaceutical Industries Ltd
-
Emzor issues US$19.8M bond to finance antimalarial API manufacturing in Nigeria
The issuance forms part of Emzor’s broader US$29.6 million bond programme, which is designed to provide capital for the company’s growth and operational needs.